Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fresenius Medical Care AG (FMS) Interest Expenses (2016 - 2025)

Historic Interest Expenses for Fresenius Medical Care AG (FMS) over the last 17 years, with Q3 2025 value amounting to $108.8 million.

  • Fresenius Medical Care AG's Interest Expenses changed 0.33% to $108.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $427.0 million, marking a year-over-year decrease of 553.39%. This contributed to the annual value of $434.9 million for FY2024, which is 466.47% down from last year.
  • As of Q3 2025, Fresenius Medical Care AG's Interest Expenses stood at $108.8 million, which was down 0.33% from $109.3 million recorded in Q2 2025.
  • Fresenius Medical Care AG's Interest Expenses' 5-year high stood at $124.1 million during Q3 2023, with a 5-year trough of $90.0 million in Q2 2022.
  • Its 5-year average for Interest Expenses is $106.1 million, with a median of $108.8 million in 2021.
  • Its Interest Expenses has fluctuated over the past 5 years, first crashed by 1522.7% in 2022, then skyrocketed by 3301.01% in 2023.
  • Over the past 5 years, Fresenius Medical Care AG's Interest Expenses (Quarter) stood at $108.8 million in 2021, then fell by 6.13% to $102.1 million in 2022, then rose by 16.79% to $119.2 million in 2023, then decreased by 9.51% to $107.9 million in 2024, then rose by 0.87% to $108.8 million in 2025.
  • Its Interest Expenses stands at $108.8 million for Q3 2025, versus $109.3 million for Q2 2025 and $101.0 million for Q1 2025.